Dyne Therapeutics, Inc. (DYN) Operating income 2019–2025
Dyne Therapeutics, Inc. (DYN) annual operating income history from SEC filings — each fiscal year as reported.
-$468.2MFY2025 · since FY2019: -$13.8M → -$468.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$468.2M | -36.1% |
| FY2024 | -$343.9M | -42.0% |
| FY2023 | -$242.2M | -41.6% |
| FY2022 | -$171.0M | -14.0% |
| FY2021 | -$150.0M | -155.8% |
| FY2020 | -$58.6M | -324.2% |
| FY2019 | -$13.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice